We are a healthcare innovation company with a unique way of diagnosing cardiovascular risks in respiratory disease patients. Since CVDs are common in people with chronic obstructive respiratory disease (COPD) / asthma / interstitial lung disease (ILD), and their presence is associated with increased risk for hospitalization, longer length of stay and all-cause and CVD-related mortality, the goal is to analyse the digital biomarkers for evaluating risk of acute exacerbation for these diseases by measuring vital and hemodynamic parameters simultaneously. We are building a patent-pending wearable healthcare platform using IoT & Mobile technology to enable healthcare professionals a precise snapshot of respiratory sound profile, along with vital and hemodynamic parameters in less than a minute.
Company’s Keywords:
<0
<
<2020
Your request has been submitted successfully.
Own or work here?